A cross-sectional analysis associated both insomnia and benzodiazepine use with erectile dysfunction. Their combined association was not proof of a pharmacologic interaction.
The study compared adult men with and without erectile dysfunction using logistic regression. Adjusted odds ratios were 2.05 for insomnia and 2.14 for benzodiazepine use. Men with both exposures had an adjusted odds ratio of 3.96, with a wide confidence interval of 1.51–10.40.
The authors described the joint finding as consistent with the combination expected from the individual associations. A larger joint estimate alone does not demonstrate biological synergy.
The cross-sectional design cannot reliably establish whether medication, sleep disturbance, or sexual symptoms came first. Clinical selection, coexisting conditions, and incompletely measured psychological factors may contribute.
The accompanying computational analysis compared molecular descriptors and predicted properties. It did not directly demonstrate a receptor mechanism, altered sexual physiology, or causation in the participants.
The paper supports asking about sleep, medication timing, and other medical explanations when symptoms coexist. It cannot establish that a benzodiazepine caused an individual’s dysfunction, quantify that contribution, or predict reversal after a medication change. Odds ratios should not be described as individual probabilities.
Original analysis of the supplied journal article, identified as PMC12524568.